focus -WSS

focus

author：leisure time 2025-09-06 05:54:06 - browse：66237

Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT — Adobe

At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Do masks work? RCTs can't tell us

WSS

#NeedHerScience: shining a light on gender disparities in medicine

Dexcom's push to bring CGM to type 2 diabetes patients

Prescription digital therapeutics are key to pharma’s future

Death of patient in Alzheimer’s trial raises question of possible risks

Crowdfunding for unproven stem cell procedures spreads misinformation

The science behind Janet Jackson's pregnancy at 49

entertainment

focus

focus

Trump demands the U.S. pay no more for drugs than other countries … again

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

As demand for Covid shots wanes, Moderna seeks its next success

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The strategy behind pharma's lawsuits over drug pricing reform

Peter Hotez and the public health issue of online harassment

Use doctors trained outside the U.S. to ease the physician shortage

At least 13 dead in Texas as scorching temps continue

#NeedHerScience: shining a light on gender disparities in medicine

focus

The biotech scorecard for Q3: 15 stock

In areas with more Black doctors, Black people live longer

Canadians with cystic fibrosis outlive Americans by a decade

Ask STAT: What do you want to know about ChatGPT in medicine?

Beware reading your test results before your doctor does

The battle over the Brookhaven Landfill on Long Island

hotspot

hotspot

explore

focus